Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,963 public trials 2,020 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Phase II Safety and Efficacy Study of Single-agent AT-101 in Patients With Relapsed or Refractory B-cell Malignancies

NCT00275431

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Diffuse Large Cell Lymphoma, +24 more
Locations: Birmingham, Alabama, United States

San Diego, California, United States

Atlanta, Georgia, United States

Chicago, Illinois, United States

View Trial Details

Completed

Study of IMC-3G3 in Patients With Tumors That Are Not Responding to Standard Therapies or No Therapy is Available

NCT00768391

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: ImClone Investigational Site Indianapolis, Indiana, United States

ImClone Investigational Site Houston, Texas, United States

View Trial Details

Completed

A Study of Tanespimycin (KOS-953) in Patients With Multiple Myeloma in First Relapse

NCT00546780

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Comprehensive Blood And Cancer Center Bakersfield, California, United States

Moores Ucsd Cancer Center La Jolla, California, United States

University Of California Medical Center San Francisco, California, United States

Rocky Mountain Cancer Centers Denver, Colorado, United States

View all 19 locations

View Trial Details

Completed

Sildenafil Citrate in Waldenstrom's Macroglobulinemia

NCT00165295

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Bortezomib (Velcade) in Waldenstrom's Macroglobulinemia

NCT00142129

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +19 more
Locations: Dana-Farber Cancer Center Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

Correlation of FC Gamma RIIIA Receptor Response in Patients With Waldenstrom's Macroglobulinemia

NCT00142155

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

NCT00003146

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia

NCT00004084

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +29 more
Locations: Garden State Cancer Center Belleville, New Jersey, United States

University of Pennsylvania Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Lymphoma or Waldenstrom's Macroglobulinemia

NCT00004107

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +37 more
Locations: Garden State Cancer Center Belleville, New Jersey, United States

St. Barnabas Medical Center Livingston, New Jersey, United States

St. Joseph's Hospital and Medical Center Paterson, New Jersey, United States

University of Pennsylvania Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

A Study Assessing Safety and Effectiveness of BORTEZOMIB Combination Therapy (Bortezomib + Doxorubicin Hydrochloride + Dexamethasone) in Previously Untreated Multiple Myeloma Patients

NCT00561743

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions